$RIGL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in RIGEL PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in RIGEL PHARMACEUTICALS INC. Get notifications about new insider transactions in RIGEL PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 5 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 28 2016 | RIGL | RIGEL PHARMACEUTIC ... | RODRIGUEZ RAUL R | CEO, President | Option Exercise | A | 2.74 | 400,000 | 1,096,000 | 400,000 | |
Jul 01 2015 | RIGL | RIGEL PHARMACEUTIC ... | Katkin Keith | Director | Option Exercise | A | 3.26 | 80,000 | 260,800 | 80,000 | |
Jun 12 2015 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | EVP, Pres. Discover ... | Option Exercise | M | 2.14 | 41,666 | 89,165 | 158,334 | |
Jun 12 2015 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | EVP, Pres. Discover ... | Sell | S | 3.68 | 41,666 | 153,214 | 58,334 | 100 K to 58.3 K (-41.67 %) |
Jun 12 2015 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | EVP, Pres. Discover ... | Buy | M | 2.14 | 41,666 | 89,165 | 100,000 | 58.3 K to 100 K (+71.43 %) |
May 14 2015 | RIGL | RIGEL PHARMACEUTIC ... | Goodwin Bradford S | Director | Option Exercise | A | 3.96 | 40,000 | 158,400 | 40,000 | |
May 14 2015 | RIGL | RIGEL PHARMACEUTIC ... | MOOS WALTER H | Director | Option Exercise | A | 3.96 | 40,000 | 158,400 | 40,000 | |
May 14 2015 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 3.96 | 40,000 | 158,400 | 40,000 | |
May 14 2015 | RIGL | RIGEL PHARMACEUTIC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 3.96 | 40,000 | 158,400 | 40,000 | |
May 14 2015 | RIGL | RIGEL PHARMACEUTIC ... | LYONS GARY A | Director | Option Exercise | A | 3.96 | 40,000 | 158,400 | 40,000 | |
Apr 03 2015 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | EVP, Pres. Discover ... | Sell | S | 3.75 | 10,000 | 37,518 | 58,334 | 68.3 K to 58.3 K (-14.63 %) |
Jan 28 2015 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 2.14 | 175,000 | 374,500 | 175,000 | |
Jan 28 2015 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Option Exercise | A | 2.14 | 175,000 | 374,500 | 175,000 | |
Jan 28 2015 | RIGL | RIGEL PHARMACEUTIC ... | Grossbard Elliott B | EVP, CMO | Option Exercise | A | 2.14 | 175,000 | 374,500 | 175,000 | |
Jan 28 2015 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | EVP, Pres. Discover ... | Option Exercise | A | 2.14 | 200,000 | 428,000 | 200,000 | |
Jan 28 2015 | RIGL | RIGEL PHARMACEUTIC ... | RODRIGUEZ RAUL R | CEO, President | Option Exercise | A | 2.14 | 450,000 | 963,000 | 450,000 | |
Dec 19 2014 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Buy | S | 2.22 | 1,000 | 2,220 | 575 | -425 to 575 (-235.29 %) |
Sep 05 2014 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | EVP, Pres. Discover ... | Sell | S | 2.56 | 20,000 | 51,200 | 68,334 | 88.3 K to 68.3 K (-22.64 %) |
May 23 2014 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 3.19 | 30,000 | 95,700 | 30,000 | |
May 23 2014 | RIGL | RIGEL PHARMACEUTIC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 3.19 | 30,000 | 95,700 | 30,000 | |
May 23 2014 | RIGL | RIGEL PHARMACEUTIC ... | MOOS WALTER H | Director | Option Exercise | A | 3.19 | 30,000 | 95,700 | 30,000 | |
May 23 2014 | RIGL | RIGEL PHARMACEUTIC ... | LYONS GARY A | Director | Option Exercise | A | 3.19 | 30,000 | 95,700 | 30,000 | |
May 23 2014 | RIGL | RIGEL PHARMACEUTIC ... | Goodwin Bradford S | Director | Option Exercise | A | 3.19 | 30,000 | 95,700 | 30,000 | |
Mar 03 2014 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 3.59 | 125,000 | 448,750 | 125,000 | |
Mar 03 2014 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Option Exercise | A | 3.59 | 125,000 | 448,750 | 125,000 | |
Mar 03 2014 | RIGL | RIGEL PHARMACEUTIC ... | Grossbard Elliott B | EVP, CMO | Option Exercise | A | 3.59 | 150,000 | 538,500 | 150,000 | |
Mar 03 2014 | RIGL | RIGEL PHARMACEUTIC ... | RODRIGUEZ RAUL R | President & COO | Option Exercise | A | 3.59 | 150,000 | 538,500 | 150,000 | |
Mar 03 2014 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | EVP, Pres. Discover ... | Option Exercise | A | 3.59 | 150,000 | 538,500 | 150,000 | |
Mar 03 2014 | RIGL | RIGEL PHARMACEUTIC ... | GOWER JAMES M | CEO & Board Chairma ... | Option Exercise | A | 3.59 | 250,000 | 897,500 | 250,000 | |
Feb 26 2014 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | EVP, Pres. Discover ... | Sell | S | 3.71 | 20,000 | 74,238 | 88,334 | 108.3 K to 88.3 K (-18.46 %) |
Nov 20 2013 | RIGL | RIGEL PHARMACEUTIC ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 2.64 | 153,056 | 404,343 | 646,559 | 799.6 K to 646.6 K (-19.14 %) |
Nov 20 2013 | RIGL | RIGEL PHARMACEUTIC ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 2.64 | 331,566 | 875,931 | 1,123,848 | 1.5 M to 1.1 M (-22.78 %) |
Jun 11 2013 | RIGL | RIGEL PHARMACEUTIC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.47 | 8,102 | 28,095 | 799,615 | 791.5 K to 799.6 K (+1.02 %) |
Jun 11 2013 | RIGL | RIGEL PHARMACEUTIC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.47 | 24,598 | 85,298 | 1,455,414 | 1.4 M to 1.5 M (+1.72 %) |
May 28 2013 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 4.87 | 15,000 | 73,050 | 15,000 | |
May 28 2013 | RIGL | RIGEL PHARMACEUTIC ... | Goodwin Bradford S | Director | Option Exercise | A | 4.87 | 15,000 | 73,050 | 15,000 | |
May 28 2013 | RIGL | RIGEL PHARMACEUTIC ... | RENTON HOLLINGS | Director | Option Exercise | A | 4.87 | 15,000 | 73,050 | 15,000 | |
May 28 2013 | RIGL | RIGEL PHARMACEUTIC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 4.87 | 15,000 | 73,050 | 15,000 | |
May 28 2013 | RIGL | RIGEL PHARMACEUTIC ... | MOOS WALTER H | Director | Option Exercise | A | 4.87 | 15,000 | 73,050 | 15,000 | |
May 28 2013 | RIGL | RIGEL PHARMACEUTIC ... | LYONS GARY A | Director | Option Exercise | A | 4.87 | 15,000 | 73,050 | 15,000 | |
Jan 31 2013 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 6.51 | 150,000 | 976,500 | 150,000 | |
Jan 31 2013 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Option Exercise | A | 6.51 | 150,000 | 976,500 | 150,000 | |
Jan 31 2013 | RIGL | RIGEL PHARMACEUTIC ... | Grossbard Elliott B | EVP, CMO | Option Exercise | A | 6.51 | 150,000 | 976,500 | 150,000 | |
Jan 31 2013 | RIGL | RIGEL PHARMACEUTIC ... | RODRIGUEZ RAUL R | President & COO | Option Exercise | A | 6.51 | 150,000 | 976,500 | 150,000 | |
Jan 31 2013 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | EVP, Pres. Discover ... | Option Exercise | A | 6.51 | 200,000 | 1,302,000 | 200,000 | |
Jan 31 2013 | RIGL | RIGEL PHARMACEUTIC ... | GOWER JAMES M | CEO & Board Chairma ... | Option Exercise | A | 6.51 | 225,000 | 1,464,750 | 225,000 | |
Sep 14 2012 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Sell | S | 10.43 | 4,151 | 43,284 | 1,103 | 5.3 K to 1.1 K (-79.01 %) |
Sep 14 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | M | 6.49 | 23,302 | 151,230 | 73,300 | |
Sep 14 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Sell | S | 10.67 | 23,302 | 248,560 | 0 | 23.3 K to 0 (-100.00 %) |
Sep 14 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Buy | M | 6.49 | 23,302 | 151,230 | 23,302 | 0 to 23.3 K |
Sep 11 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | M | 6.49 | 17,586 | 114,133 | 96,602 | |
Sep 11 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | M | 6.49 | 34,112 | 221,387 | 114,188 | |
Sep 11 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Sell | S | 10.52 | 17,586 | 184,927 | 0 | 17.6 K to 0 (-100.00 %) |
Sep 11 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Buy | M | 6.49 | 17,586 | 114,133 | 17,586 | 0 to 17.6 K |
Sep 11 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Sell | S | 10.55 | 34,112 | 359,960 | 0 | 34.1 K to 0 (-100.00 %) |
Sep 11 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Buy | M | 6.49 | 34,112 | 221,387 | 34,112 | 0 to 34.1 K |
Aug 09 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | M | 6.49 | 1,700 | 11,033 | 148,300 | |
Aug 09 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Sell | S | 10.63 | 300 | 3,188 | 0 | 300 to 0 (-100.00 %) |
Aug 09 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Sell | S | 10.62 | 600 | 6,372 | 300 | 900 to 300 (-66.67 %) |
Aug 09 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Sell | S | 10.61 | 100 | 1,061 | 900 | 1,000 to 900 (-10.00 %) |
Aug 09 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Sell | S | 10.60 | 700 | 7,420 | 1,000 | 1.7 K to 1,000 (-41.18 %) |
Aug 09 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Buy | M | 6.49 | 1,700 | 11,033 | 1,700 | 0 to 1.7 K |
Jun 20 2012 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | EVP, Pres. Discover ... | Sell | S | 8.71 | 100 | 871 | 108,334 | 108.4 K to 108.3 K (-0.09 %) |
Jun 20 2012 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | EVP, Pres. Discover ... | Sell | S | 8.70 | 9,700 | 84,390 | 108,434 | 118.1 K to 108.4 K (-8.21 %) |
Jun 20 2012 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | EVP, Pres. Discover ... | Sell | S | 8.72 | 100 | 872 | 118,134 | 118.2 K to 118.1 K (-0.08 %) |
Jun 20 2012 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | EVP, Pres. Discover ... | Sell | S | 8.75 | 100 | 875 | 118,234 | 118.3 K to 118.2 K (-0.08 %) |
May 24 2012 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 7.60 | 15,000 | 114,000 | 15,000 | |
May 24 2012 | RIGL | RIGEL PHARMACEUTIC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 7.60 | 15,000 | 114,000 | 15,000 | |
May 24 2012 | RIGL | RIGEL PHARMACEUTIC ... | RENTON HOLLINGS | Director | Option Exercise | A | 7.60 | 15,000 | 114,000 | 15,000 | |
May 24 2012 | RIGL | RIGEL PHARMACEUTIC ... | MOOS WALTER H | Director | Option Exercise | A | 7.60 | 15,000 | 114,000 | 15,000 | |
May 24 2012 | RIGL | RIGEL PHARMACEUTIC ... | LYONS GARY A | Director | Option Exercise | A | 7.60 | 15,000 | 114,000 | 15,000 | |
May 24 2012 | RIGL | RIGEL PHARMACEUTIC ... | Goodwin Bradford S | Director | Option Exercise | A | 7.60 | 15,000 | 114,000 | 15,000 | |
Jan 27 2012 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Option Exercise | A | 8.15 | 150,000 | 1,222,500 | 150,000 | |
Jan 27 2012 | RIGL | RIGEL PHARMACEUTIC ... | Grossbard Elliott B | EVP, CMO | Option Exercise | A | 8.15 | 150,000 | 1,222,500 | 150,000 | |
Jan 27 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 8.15 | 150,000 | 1,222,500 | 150,000 | |
Jan 27 2012 | RIGL | RIGEL PHARMACEUTIC ... | RODRIGUEZ RAUL R | President & COO | Option Exercise | A | 8.15 | 150,000 | 1,222,500 | 150,000 | |
Jan 27 2012 | RIGL | RIGEL PHARMACEUTIC ... | GOWER JAMES M | CEO & Board Chairma ... | Option Exercise | A | 8.15 | 225,000 | 1,833,750 | 225,000 | |
Jan 27 2012 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | EVP, Pres. Discover ... | Option Exercise | A | 8.15 | 200,000 | 1,630,000 | 200,000 | |
Jun 07 2011 | RIGL | RIGEL PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.00 | 301,424 | 2,411,392 | 3,204,167 | 2.9 M to 3.2 M (+10.38 %) |
Jun 07 2011 | RIGL | RIGEL PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.00 | 229,252 | 1,834,016 | 2,279,997 | 2.1 M to 2.3 M (+11.18 %) |
Jun 07 2011 | RIGL | RIGEL PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.00 | 72,800 | 582,400 | 762,700 | 689.9 K to 762.7 K (+10.55 %) |
Jun 07 2011 | RIGL | RIGEL PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.00 | 46,524 | 372,192 | 470,425 | 423.9 K to 470.4 K (+10.98 %) |
May 20 2011 | RIGL | RIGEL PHARMACEUTIC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 8.34 | 15,000 | 125,025 | 15,000 | |
May 20 2011 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 8.34 | 15,000 | 125,025 | 15,000 | |
May 20 2011 | RIGL | RIGEL PHARMACEUTIC ... | RENTON HOLLINGS | Director | Option Exercise | A | 8.34 | 15,000 | 125,025 | 15,000 | |
May 20 2011 | RIGL | RIGEL PHARMACEUTIC ... | MOOS WALTER H | Director | Option Exercise | A | 8.34 | 15,000 | 125,025 | 15,000 | |
May 20 2011 | RIGL | RIGEL PHARMACEUTIC ... | LYONS GARY A | Director | Option Exercise | A | 8.34 | 15,000 | 125,025 | 15,000 | |
May 20 2011 | RIGL | RIGEL PHARMACEUTIC ... | Goodwin Bradford S | Director | Option Exercise | A | 8.34 | 15,000 | 125,025 | 15,000 | |
Feb 03 2011 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Option Exercise | A | 6.73 | 65,000 | 437,450 | 65,000 | |
Feb 03 2011 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 6.73 | 65,000 | 437,450 | 65,000 | |
Feb 03 2011 | RIGL | RIGEL PHARMACEUTIC ... | Grossbard Elliott B | EVP, CMO | Option Exercise | A | 6.73 | 65,000 | 437,450 | 65,000 | |
Feb 03 2011 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | EVP, Pres. Discover ... | Option Exercise | A | 6.73 | 65,000 | 437,450 | 65,000 | |
Feb 03 2011 | RIGL | RIGEL PHARMACEUTIC ... | RODRIGUEZ RAUL R | President & COO | Option Exercise | A | 6.73 | 65,000 | 437,450 | 65,000 | |
Feb 03 2011 | RIGL | RIGEL PHARMACEUTIC ... | GOWER JAMES M | CEO & Board Chairma ... | Option Exercise | A | 6.73 | 65,000 | 437,450 | 65,000 | |
Nov 05 2010 | RIGL | RIGEL PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 7.55 | 3,690 | 27,860 | 2,902,743 | 2.9 M to 2.9 M (-0.13 %) |
Nov 05 2010 | RIGL | RIGEL PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 7.55 | 2,605 | 19,668 | 2,050,745 | 2.1 M to 2.1 M (-0.13 %) |
Nov 05 2010 | RIGL | RIGEL PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 7.55 | 900 | 6,795 | 689,900 | 690.8 K to 689.9 K (-0.13 %) |
Nov 05 2010 | RIGL | RIGEL PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 7.55 | 516 | 3,896 | 423,901 | 424.4 K to 423.9 K (-0.12 %) |
Jun 01 2010 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Option Exercise | A | 6.55 | 67,000 | 438,850 | 67,000 | |
Jun 01 2010 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 6.55 | 120,000 | 786,000 | 120,000 | |
Jun 01 2010 | RIGL | RIGEL PHARMACEUTIC ... | RODRIGUEZ RAUL R | President & COO | Option Exercise | A | 6.55 | 175,000 | 1,146,250 | 175,000 | |
May 28 2010 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 6.73 | 15,000 | 100,950 | 15,000 | |
May 28 2010 | RIGL | RIGEL PHARMACEUTIC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 6.73 | 15,000 | 100,950 | 15,000 | |
May 28 2010 | RIGL | RIGEL PHARMACEUTIC ... | RENTON HOLLINGS | Director | Option Exercise | A | 6.73 | 15,000 | 100,950 | 15,000 | |
May 28 2010 | RIGL | RIGEL PHARMACEUTIC ... | MOOS WALTER H | Director | Option Exercise | A | 6.73 | 15,000 | 100,950 | 15,000 | |
May 28 2010 | RIGL | RIGEL PHARMACEUTIC ... | LYONS GARY A | Director | Option Exercise | A | 6.73 | 15,000 | 100,950 | 15,000 | |
May 28 2010 | RIGL | RIGEL PHARMACEUTIC ... | Goodwin Bradford S | Director | Option Exercise | A | 6.73 | 15,000 | 100,950 | 15,000 | |
May 28 2010 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Option Exercise | A | 6.73 | 15,000 | 100,950 | 15,000 | |
Jan 25 2010 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | VP, CFO | Option Exercise | A | 9.62 | 85,000 | 817,700 | 85,000 | |
Jan 25 2010 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | SVP, Gen. Counsel, ... | Option Exercise | A | 9.62 | 105,000 | 1,010,100 | 105,000 | |
Jan 25 2010 | RIGL | RIGEL PHARMACEUTIC ... | Grossbard Elliott B | EVP, CMO | Option Exercise | A | 9.62 | 115,000 | 1,106,300 | 115,000 | |
Jan 25 2010 | RIGL | RIGEL PHARMACEUTIC ... | RODRIGUEZ RAUL R | EVP, COO | Option Exercise | A | 9.62 | 125,000 | 1,202,500 | 125,000 | |
Jan 25 2010 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | EVP, Pres. Discover ... | Option Exercise | A | 9.62 | 165,000 | 1,587,300 | 165,000 | |
Jan 25 2010 | RIGL | RIGEL PHARMACEUTIC ... | GOWER JAMES M | CEO & Board Chairma ... | Option Exercise | A | 9.62 | 220,000 | 2,116,400 | 220,000 | |
May 29 2009 | RIGL | RIGEL PHARMACEUTIC ... | LYONS GARY A | Director | Option Exercise | A | 8.12 | 10,000 | 81,200 | 10,000 | |
May 29 2009 | RIGL | RIGEL PHARMACEUTIC ... | MOOS WALTER H | Director | Option Exercise | A | 8.12 | 10,000 | 81,200 | 10,000 | |
May 29 2009 | RIGL | RIGEL PHARMACEUTIC ... | RENTON HOLLINGS | Director | Option Exercise | A | 8.12 | 10,000 | 81,200 | 10,000 | |
May 29 2009 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 8.12 | 10,000 | 81,200 | 10,000 | |
May 29 2009 | RIGL | RIGEL PHARMACEUTIC ... | Goodwin Bradford S | Director | Option Exercise | A | 8.12 | 10,000 | 81,200 | 10,000 | |
May 29 2009 | RIGL | RIGEL PHARMACEUTIC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 8.12 | 10,000 | 81,200 | 10,000 | |
May 29 2009 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Option Exercise | A | 8.12 | 10,000 | 81,200 | 10,000 | |
Mar 31 2009 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | VP, CFO | Option Exercise | A | 6.49 | 150,000 | 973,500 | 150,000 | |
Mar 31 2009 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | SVP, Gen. Counsel, ... | Option Exercise | A | 6.49 | 100,000 | 649,000 | 100,000 | |
Mar 31 2009 | RIGL | RIGEL PHARMACEUTIC ... | RODRIGUEZ RAUL R | EVP, COO | Option Exercise | A | 6.49 | 115,000 | 746,350 | 115,000 | |
Mar 31 2009 | RIGL | RIGEL PHARMACEUTIC ... | Grossbard Elliott B | EVP, CMO | Option Exercise | A | 6.49 | 115,000 | 746,350 | 115,000 | |
Mar 31 2009 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | EVP, Pres. Discover ... | Option Exercise | A | 6.49 | 145,000 | 941,050 | 145,000 | |
Mar 31 2009 | RIGL | RIGEL PHARMACEUTIC ... | GOWER JAMES M | CEO & Board Chairma ... | Option Exercise | A | 6.49 | 190,000 | 1,233,100 | 190,000 | |
Jan 06 2009 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | EVP, Pres. Discover ... | Option Exercise | M | 1.80 | 3,334 | 6,001 | 0 | |
Jan 06 2009 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | EVP, Pres. Discover ... | Buy | M | 1.80 | 3,334 | 6,001 | 118,334 | 115 K to 118.3 K (+2.90 %) |
Jan 06 2009 | RIGL | RIGEL PHARMACEUTIC ... | GOWER JAMES M | CEO & Board Chairma ... | Option Exercise | M | 1.80 | 50,000 | 90,000 | 0 | |
Jan 06 2009 | RIGL | RIGEL PHARMACEUTIC ... | GOWER JAMES M | CEO & Board Chairma ... | Buy | M | 1.80 | 50,000 | 90,000 | 180,676 | 130.7 K to 180.7 K (+38.26 %) |
Jan 06 2009 | RIGL | RIGEL PHARMACEUTIC ... | GOWER JAMES M | CEO & Board Chairma ... | Buy | J | 0.00 | 297 | 0 | 126,736 | 126.4 K to 126.7 K (+0.23 %) |
May 30 2008 | RIGL | RIGEL PHARMACEUTIC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 23.10 | 10,000 | 231,000 | 10,000 | |
May 30 2008 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 23.10 | 10,000 | 231,000 | 10,000 | |
May 30 2008 | RIGL | RIGEL PHARMACEUTIC ... | RENTON HOLLINGS | Director | Option Exercise | A | 23.10 | 10,000 | 231,000 | 10,000 | |
May 30 2008 | RIGL | RIGEL PHARMACEUTIC ... | MOOS WALTER H | Director | Option Exercise | A | 23.10 | 10,000 | 231,000 | 10,000 | |
May 30 2008 | RIGL | RIGEL PHARMACEUTIC ... | LYONS GARY A | Director | Option Exercise | A | 23.10 | 10,000 | 231,000 | 10,000 | |
May 30 2008 | RIGL | RIGEL PHARMACEUTIC ... | Goodwin Bradford S | Director | Option Exercise | A | 23.10 | 10,000 | 231,000 | 10,000 | |
May 30 2008 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Option Exercise | A | 23.10 | 10,000 | 231,000 | 10,000 | |
Feb 04 2008 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | VP, CFO | Option Exercise | A | 26.45 | 75,000 | 1,983,750 | 75,000 | |
Feb 04 2008 | RIGL | RIGEL PHARMACEUTIC ... | COOPER ROBIN D G | Sr. V.P. Pharmaceut ... | Option Exercise | A | 26.45 | 10,000 | 264,500 | 10,000 | |
Feb 04 2008 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | SVP, Gen. Counsel, ... | Option Exercise | A | 26.45 | 90,000 | 2,380,500 | 90,000 | |
Feb 04 2008 | RIGL | RIGEL PHARMACEUTIC ... | Grossbard Elliott B | EVP, CMO | Option Exercise | A | 26.45 | 130,000 | 3,438,500 | 130,000 | |
Feb 04 2008 | RIGL | RIGEL PHARMACEUTIC ... | RODRIGUEZ RAUL R | EVP, COO | Option Exercise | A | 26.45 | 125,000 | 3,306,250 | 125,000 | |
Feb 04 2008 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | EVP, Pres. Discover ... | Option Exercise | A | 26.45 | 140,000 | 3,703,000 | 140,000 | |
Feb 04 2008 | RIGL | RIGEL PHARMACEUTIC ... | GOWER JAMES M | CEO & Board Chairma ... | Option Exercise | A | 26.45 | 165,000 | 4,364,250 | 165,000 | |
Aug 10 2007 | RIGL | RIGEL PHARMACEUTIC ... | Goodwin Bradford S | Director | Buy | P | 10.00 | 5,000 | 50,000 | 10,000 | 5 K to 10 K (+100.00 %) |
Aug 10 2007 | RIGL | RIGEL PHARMACEUTIC ... | Goodwin Bradford S | Director | Buy | P | 9.87 | 1,815 | 17,914 | 5,000 | 3.2 K to 5 K (+56.99 %) |
Aug 10 2007 | RIGL | RIGEL PHARMACEUTIC ... | Goodwin Bradford S | Director | Buy | P | 9.86 | 1,385 | 13,656 | 3,185 | 1.8 K to 3.2 K (+76.94 %) |
Aug 10 2007 | RIGL | RIGEL PHARMACEUTIC ... | Goodwin Bradford S | Director | Buy | P | 9.85 | 800 | 7,880 | 1,800 | 1,000 to 1.8 K (+80.00 %) |